User menu

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial.

Bibliographic reference Tannock, Ian F ; Fizazi, Karim ; Ivanov, Sergey ; Karlsson, Camilla Thellenberg ; Fléchon, Aude ; et. al. Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial.. In: The Lancet Oncology, Vol. 14, no.8, p. 760-8 (2013)
Permanent URL http://hdl.handle.net/2078.1/132779